Welcome to the UC Irvine - UroToday Urology Education Corner - Jaime Landman
UroToday.com and Digital Science Press, Inc. welcome you to the UC Irvine Department of Urology Education Corner. Formed from a collaboration of mutual benefit to extend access to the UroToday audience of the clinical practice developments and educational exchange from the University of California, Irvine (UCI). This channel will deliver content from conferences, publications, and grand rounds led from academicians at UCI. To date we have posted 10 videos of presentations from the AUA 2016 as contributed from the UCI faculty team. We look forward to bringing you additional content from Dr. Landman and his team.
Biography: Jaime Landman, MD. Professor and Chairman Department of Urology - University of California, Irvine Medical Center.
Dr. Jaime Landman has served as the chair of the Department of Urology since January 2011. He brings to UC Irvine Medical Center highly valued expertise from his former position as the director of minimally invasive urology in the Department of Urology at Columbia University College of Physicians and Surgeons in New York. Dr. Landman has extensive clinical expertise in laparoscopic and endoscopic kidney surgery for the management of urinary tract pathology including kidney stones, kidney cancer and ureteropelvic junction obstruction. He has pioneered technologies and techniques for minimally invasive management of kidney stones and kidney tumors and has developed novel techniques that are used globally for laparoscopic partial nephrectomy, ureteroscopy and percutaneous nephrolithotomy. Dr. Landman is respected as an international expert in the management of kidney cancer and is a pioneer and recognized expert on the application of minimally invasive techniques for ablation of kidney cancer. Dr. Landman has helped re-define the diagnosis of kidney cancer by developing novel diagnostic biopsy techniques which has provided patients more precise treatment of their disease. He directs the course on management of small renal tumors at the annual meeting of the American Urological Association as well as the small renal mass mini-fellowship at the University of California, Irvine. Dr. Landman developed and tested novel ablation devices, which are currently used for minimally invasive ablation of renal tumors and malignancies. He has also invented novel technologies for the diagnosis of kidney cancer. His research focuses on stone disease, and he pioneered the combined antegrade and retrograde approach for treatment of complex kidney stones. Working in collaboration with basic scientist, he is actively working on tumor markers for urologic cancers and is trying to identify the relationship between kidney cancer and surrounding tissues.